Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy
Suneil Jain(Queen's University Belfast), David Waugh(University of South Australia), Paul Medlow(Almac (United Kingdom)), Christopher Steele(Almac (United Kingdom)), Darragh G. McArt(Queen's University Belfast), C. Lyons(Cork University Hospital), Stephen McQuaid(Queen's University Belfast), Joe M. O’Sullivan(San Antonio College), Jacqueline A. James(Queen's University Belfast), Seán O. Hynes(University Hospital Galway), Steven M. Walker(Almac (United Kingdom)), D.A. Loblaw(American Society of Clinical Oncology), Andrena McCavigan(Almac (United Kingdom)), Simon S. McDade(Queen's University Belfast), Brendan Pang(National University Cancer Institute, Singapore), Kevin M. Prise(Queen's University Belfast), Gemma E. Logan(Almac (United Kingdom)), Ian G. Mills(Queen's University Belfast), Richard D. Kennedy(Queen's University Belfast), Laura A. Knight(Almac (United Kingdom)), D. Paul Harkin(Almac (United Kingdom)), Betina Katz(Oslo University Hospital), D. Mitchell(University of Ulster), Declan O’Rourke(University of Ulster), Viktor Berge(Oslo University Hospital)
Cited by 133
Related Papers
QuPath: Open source software for digital pathology image analysis
|Scientific Reports|2017|8.9k
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
QuPath: Open source software for digital pathology image analysis
|bioRxiv (Cold Spring Harbor Laboratory)|2017|809